title: The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure.
authors.affiliation: Mapi, Toronto, ON, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Burnett
authors.affiliation: Mapi, Toronto, ON, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Cope
authors.affiliation: Novartis Pharma, Health Economics and Outcomes Research, USA, East Hanover, NJ, USA.
authors.forename: M C
authors.initials: MC
authors.lastname: Vieira
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Sagkriotis
authors.affiliation: Scompenso e Trapianti di Cuore, Bergamo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Senni
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: C
authors.initials: C
authors.lastname: Deschaseaux